Lanzatech Global, INC 8-K filings

LanzaTech Global, Inc. has entered into a $60 million loan agreement with Brookfield Asset Management, replacing a previous Simple Agreement for Future Equity (SAFE) and solidifying their partnership for project development.

LanzaTech Global, Inc. appoints Reyad Fezzani, Chairman and CEO of Regenerate Power LLC, to its Board of Directors, leveraging his extensive experience in global energy markets and renewable energy innovation.

LanzaTech plans to spin out its synthetic biology platform, LanzaX, into a joint venture with Tharsis Capital and appoints Justin Pugh as Interim CFO to focus on cost reductions and SAF opportunities.

LanzaTech and Technip Energies have been awarded up to $200 million in federal funding to advance their Project SECURE, aimed at producing sustainable ethylene from captured CO2 emissions.

LanzaTech has appointed Sushmita Koyanagi as Chief Accounting Officer and George Dimitrov as Senior Vice President of Finance and Business Operations for its Nutritional Protein division.

LanzaTech's CEO presented at the ChemIndix conference, detailing the company's approach to enabling a circular carbon economy through innovative biotechnology.

LanzaTech has appointed Thierry Pilenko, former Executive Chairman of TechnipFMC, to its Board of Directors, bringing extensive experience in energy and infrastructure.

LanzaTech's third-quarter 2024 revenue fell short of expectations due to a delay in a key sublicensing agreement, but the company is expanding its business model to include more direct ethanol sales and project ownership.

LanzaTech and Eramet are collaborating on a first-of-its-kind integrated carbon capture, utilization, and storage project in Norway, aiming to produce ethanol and significantly reduce CO2 emissions.

LanzaTech Global, Inc. has settled its Forward Purchase Agreement with ACM ARRT H LLC, resulting in a cash payment and a reduction of approximately 2.9 million outstanding shares.

LanzaTech is dealing with an accelerated settlement of a forward purchase agreement and has clarified its financing plans after a media report.

LanzaTech Global's stockholders approved an increase in authorized common stock shares from 400 million to 600 million to support the conversion of convertible notes.

LanzaTech is expanding its biorefining platform to include the primary production of commercial-scale nutritional protein directly from CO2, aiming to tap into the $1 trillion alternative protein market.

LanzaTech Global, Inc. has entered into a convertible note purchase agreement to raise up to $150 million, with an initial closing of $40.15 million.

LanzaTech reported strong second-quarter 2024 results, exceeding revenue expectations, securing a $40 million investment, and reaffirming its full-year 2024 financial outlook.

LanzaTech is in a legal dispute with Vellar Opportunity Fund SPV LLC over the acceleration of a forward purchase agreement and the sale of shares.

LanzaTech Global's 2024 Annual Meeting saw shareholders approve the election of directors, ratify the accounting firm, and vote on executive compensation matters.

LanzaTech has increased its ownership in LanzaJet to approximately 36% following the first of three planned equity issuances related to the licensing of its Alcohol-to-Jet technology.

LanzaTech reported first quarter 2024 financial results in line with expectations, secured a potential $200 million grant for Project SECURE, and reiterated its full-year 2024 revenue guidance.

Nimesh Patel, a non-independent director of LanzaTech Global, Inc., has resigned from the board effective immediately, with the company initiating a search for an independent replacement.

LanzaTech and Technip Energies have been selected by the U.S. Department of Energy to negotiate up to $200 million in funding for Project SECURE, aimed at converting CO2 emissions into sustainable ethylene.

LanzaTech reported a 77% increase in fourth-quarter revenue and provided a full-year 2024 revenue outlook of $90 million to $105 million, while also announcing a management reorganization and cost-cutting measures.